Project Grant R37CA296976
Award Date 8/14/25
Completion Date 7/31/30
Dollars Obligated $688K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
New Jersey, USA
Similar Awards
- This federal Project Grant award in the amount of $403,689 was provided by the National Cancer Institute (NCI), under the Cancer Cause and Prevention Research program (CFDA 93.393), to Rutgers, The State University of New Jersey. The purpose of the grant is to investigate the influence of menthol cigarette smoking on lung cancer screening eligibility in a national prospective study. The award period runs from August 1, 2025 through July 31, 2027. Rutgers will conduct comprehensive research to...
- This federal Project Grant award of $619,175 from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) supports a Type 1 hybrid effectiveness-implementation trial to evaluate a novel harm reduction approach for oncology outpatients who smoke but refuse traditional tobacco treatment. The study will directly compare rates of switching from cigarettes to e-cigarettes against standard care, while also assessing key barriers and facilitators to implementation. The...
- The federal Project Grant award titled "Catalyzing Cigarette Smoking Cessation Through Harm Reduction Sampling Among People Unmotivated to Quit" is funded by the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) for $663,554.00 with an award date of August 18, 2025 and an ultimate completion date of July 31, 2030. The grant supports research to explore the use of harm reduction product sampling, such as e-cigarettes, heated tobacco products, and oral...
- This $515,632 Project Grant from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) supports research to prepare the U.S. and states for potential new cigarette product standards that could significantly increase smoking cessation rates. The research team at the University of Minnesota will provide state-specific estimates of the number of people who smoke (PWS) that will quit smoking in response to a menthol ban and nicotine reduction standard, as well as the...
- The National Cancer Institute (NCI) awarded a Project Grant under the Cancer Cause and Prevention Research program (CFDA 93.393) to the University of Oklahoma Health Sciences Center to conduct a randomized factorial trial on smoking cessation interventions. The $625,201 award, effective January 1, 2025 through December 31, 2029, will evaluate the combined impact of varenicline medication plus nicotine lozenges, and a smartphone-based medication adherence intervention, on 7-day point prevalence...
- The National Cancer Institute (NCI) awarded a $399,891 Project Grant under the Cancer Cause and Prevention Research program (CFDA 93.393) to Sensewhy, Inc. (UEI: N7FTT2U8NHX7) to evaluate the feasibility and clinical utility of the "Smokemon" wearable device for detecting smoking topography and predicting smoking lapses among cancer survivors who are daily smokers. The project will involve a one-week pre-quit observation period and a four-week post-quit observation period, during which...
- This Project Grant award of $371,822, funded by the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) and awarded on February 1, 2025, aims to advance the science on the impact of cigar package quantity on cigar use behaviors. The research project has two key objectives: 1) Characterize changes in cigar pack size over time and assess its impact on sales, consumption, and patterns of use using secondary data sources; and 2) Examine how pack size, price, and flavor...
- The University of Pittsburgh received a $2,202,321 Project Grant from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) to conduct an experimental investigation on the impact of dyadic processes on smoking and cigarette craving. The 4-year project, running from August 2025 to July 2029, will examine how social factors, particularly romantic partner and friend dynamics, influence smoking behaviors and craving in an effort to develop a more comprehensive...
- This federal Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) totaling $885,824 aims to assess consumer response to smokeless tobacco modified risk marketing orders. The research activities will explore 1) consumers' exposure and reactions to authorized smokeless tobacco modified risk tobacco product (MRTP) claims, and 2) whether the MRTP claims influence smokeless tobacco demand and sensory evaluations. The project will be conducted...
- This federal Project Grant award of $164,484.00 from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) supports the development and evaluation of smoking cessation messages targeted to adults who smoke nondaily. The project, conducted by the University of Kentucky Research Foundation, aims to create tailored communications that increase knowledge, worry, risk perceptions, motivation, and intentions to quit smoking among this population. The researchers will...